Royalty payments in patent licensing

Key points to take away from recent UK cases on patent licence agreements

Cases concerning patent licences in the English courts are a bit like London buses: you don’t see any for a very long time and then three turn up at once.

In this article, Matthew Warren, Sean Hess and Sebastian Stewart discuss:

• Eteboxagu AB v Cycle Pharmaceuticals Ltd [2023] EWHC 462 (Comm)
• Oxford University Innovation Ltd v Oxford Nanoimaging Ltd [2022] EWHC 3200 (Pat)
• AstraZeneca UK Ltd v Tesaro, Inc. [2023] EWHC 803 (Ch)